PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trialFlorian Lordick, J. R. Siewert, Hinrich Wieder et al.|The Lancet Oncology|2007Cited by 808
Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to TreatmentHinrich Wieder, Wolfgang Weber, Björn L.D.M. Brücher et al.|Journal of Clinical Oncology|2004Cited by 460
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective TrialKatja Ott, Wolfgang Weber, U. Fink et al.|Journal of Clinical Oncology|2003Cited by 320
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago–gastric junction and the stomachPernilla Lagergren, Jane Blazeby, Peter Fayers et al.|European Journal of Cancer|2007Cited by 217